Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vascular smooth muscle cell proliferation in restenosis.

Literature DB >> 21325199

Vascular smooth muscle cell proliferation in restenosis.

Steven O Marx¹, Hana Totary-Jain, Andrew R Marks.

Abstract

Entities: CellLine Chemical Disease Gene Species

Mesh：

Year: 2011 PMID： 21325199 PMCID： PMC3816546 DOI： 10.1161/CIRCINTERVENTIONS.110.957332

Source DB: PubMed Journal: Circ Cardiovasc Interv ISSN： 1941-7640 Impact factor: 6.546

× No keyword cloud information.

99 in total

Review 1. Inflammation and restenosis in the stent era.

Authors: Frederick G P Welt; Campbell Rogers
Journal: Arterioscler Thromb Vasc Biol Date: 2002-11-01 Impact factor: 8.311

Review 2. Molecular basis of restenosis and drug-eluting stents.

Authors: Marco A Costa; Daniel I Simon
Journal: Circulation Date: 2005-05-03 Impact factor: 29.690

Review 3. Getting to the root of miRNA-mediated gene silencing.

Authors: Ana Eulalio; Eric Huntzinger; Elisa Izaurralde
Journal: Cell Date: 2008-01-11 Impact factor: 41.582

Review 4. Cell cycle checkpoints: preventing an identity crisis.

Authors: S J Elledge
Journal: Science Date: 1996-12-06 Impact factor: 47.728

5. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

Authors: K Polyak; J Y Kato; M J Solomon; C J Sherr; J Massague; J M Roberts; A Koff
Journal: Genes Dev Date: 1994-01 Impact factor: 11.361

6. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.

Authors: Masataka Sata; Akio Saiura; Atsushi Kunisato; Akihiro Tojo; Seiji Okada; Takeshi Tokuhisa; Hisamaru Hirai; Masatoshi Makuuchi; Yasunobu Hirata; Ryozo Nagai
Journal: Nat Med Date: 2002-04 Impact factor: 53.440

7. Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).

Authors: Martin B Leon; David E Kandzari; Eric L Eisenstein; Kevin J Anstrom; Laura Mauri; Donald E Cutlip; Eugenia Nikolsky; Charles O'Shaughnessy; Paul A Overlie; Ajay J Kirtane; Brent T McLaurin; Stuart L Solomon; John S Douglas; Jeffrey J Popma
Journal: JACC Cardiovasc Interv Date: 2009-12 Impact factor: 11.195

8. Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels.

Authors: C R Gregory; P Huie; M E Billingham; R E Morris
Journal: Transplantation Date: 1993-06 Impact factor: 4.939

9. A mammalian protein targeted by G1-arresting rapamycin-receptor complex.

Authors: E J Brown; M W Albers; T B Shin; K Ichikawa; C T Keith; W S Lane; S L Schreiber
Journal: Nature Date: 1994-06-30 Impact factor: 49.962

10. Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase.

Authors: A D Kohn; K S Kovacina; R A Roth
Journal: EMBO J Date: 1995-09-01 Impact factor: 11.598

114 in total

1. In vivo nanoparticle assessment of pathological endothelium predicts the development of inflow stenosis in murine arteriovenous fistula.

Authors: Jie Cui; Chase W Kessinger; Jason R McCarthy; David E Sosnovik; Peter Libby; Ravi I Thadhani; Farouc A Jaffer
Journal: Arterioscler Thromb Vasc Biol Date: 2014-11-13 Impact factor: 8.311

10. Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells.

Authors: Izuagie Attairu Ikhapoh; Christopher J Pelham; Devendra K Agrawal
Journal: Differentiation Date: 2015-04-23 Impact factor: 3.880

Vascular smooth muscle cell proliferation in restenosis.

Review 1. Inflammation and restenosis in the stent era.

Review 2. Molecular basis of restenosis and drug-eluting stents.

Review 3. Getting to the root of miRNA-mediated gene silencing.

Review 4. Cell cycle checkpoints: preventing an identity crisis.

5. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

6. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.

8. Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels.

9. A mammalian protein targeted by G1-arresting rapamycin-receptor complex.

10. Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase.

1. In vivo nanoparticle assessment of pathological endothelium predicts the development of inflow stenosis in murine arteriovenous fistula.

2. TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells.

3. Abl regulates smooth muscle cell proliferation by modulating actin dynamics and ERK1/2 activation.

4. Electrophoretic coating of amphiphilic chitosan colloids on regulating cellular behaviour.

5. Pulmonary vein stenosis in patients with Smith-Lemli-Opitz syndrome.

Review 6. Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.

7. MicroRNAs and Cardiovascular Disease.

8. An in silico study on the role of smooth muscle cell migration in neointimal formation after coronary stenting.

9. Mathematical modelling of the restenosis process after stent implantation.

10. Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells.